Most oncology research optimises for efficacy first and cost never. That sequence produces therapies that work and that most of the world cannot obtain. We wanted to know what happens if affordability and supply are treated as constraints at the start rather than as a distribution problem to solve afterwards.
Why a by-product
Rice is a staple for roughly half the world, and milling it produces an enormous, renewable stream of by-product that is already generated at scale, everywhere, as a matter of course. A compound sourced from that stream starts with properties a novel molecule has to fight for: it is abundant, it is cheap, it is produced near the people who would need it, and scaling it does not require building a supply chain that does not exist.
That is the thesis being tested. It is a starting hypothesis about sourcing, not a result about medicine.
Where the evidence gathering stands
This is an ongoing pre-clinical programme: laboratory work, running now, accumulating evidence rather than sitting on a conclusion. It does not involve human trials, it has not produced a candidate therapy, and nothing has been shown to treat any disease in any person.
Evidence gathering means exactly that — results for and against the thesis are both data, and the programme is designed to keep collecting either way. We are naming neither specific cancer types nor specific compounds yet, because at this stage naming them would imply a level of confidence the evidence has not yet earned. When there are results worth naming, they will be named — along with whatever did not work.
Why publish while the work is still running
Announcing research only after it succeeds is how a field ends up looking more certain than it is. Publishing while the evidence is still being gathered means the record shows the attempt whether or not it works — and it lets this note be read for what it is, a programme in motion, rather than mistaken for a finding.
This note will be updated as the evidence does.
What this deliberately does not do
- No efficacy has been demonstrated. Nothing here treats, prevents, or cures any disease
- There are no human trials and no treatment available to anyone
- Nothing in this note should inform a treatment decision. Cancer care belongs with your oncologist
- Lunas does not sell, supply, or recommend any cancer therapy, and eating rice or rice bran is not a cancer treatment